Vertex Pharmaceuticals(VRTX) · US
Sector: XLV | Last updated: 28 Aug 2026
Vertex Pharmaceuticals (VRTX) is showing Bullish momentum today, with an Altra Score of 73.8 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the XLV sector, where it ranks 7 by relative strength in a currently bullish RS regime (Relative Strength: 316.48). Recent EMA crossover activity: Close below EMA 8. VRTX closed at 541.69 on 28 Aug 2026 (-0.99% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
VRTX's Daily RSI(14) is 61.4 (down 3.6 from prior), Weekly RSI is 66.9 (down 2.2 from prior), and Monthly RSI is 62.6 (up 9.8 from prior). Price is currently trading above its Daily EMA 20, Daily EMA 50, Daily EMA 200, Weekly EMA 8, Weekly EMA 30, but below its Daily EMA 8.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 61.4 | 65.1 | ▼ 3.6 |
| Weekly | 66.9 | 69.1 | ▼ 2.2 |
| Monthly | 62.6 | 52.8 | ▲ 9.8 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for VRTX is Bullish, triggered on 22 Jun 2026 at a price of 466.79. Since then, the stock has gained 16.05%.
These are long-term momentum shifts, not buy/sell recommendations.